Nantahala Capital Management’s Unicycive Therapeutics UNCY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.18M	Hold	939,202	–	–	0.39%	91
2025 Q4	$5.42M	Hold	939,202	–	–	0.32%	97
2025 Q3	$4.09M	Hold	939,202	–	–	0.25%	112
2025 Q2	$4.56M	Buy	939,202 +3	+0%	+$19	0.32%	95
2025 Q1	$5.4M	Sell	939,199 -100,000	-10%	-$610K	0.45%	65
2024 Q4	$8.25M	Buy	1,039,199 +757,163	+268%	+$4.19M	0.58%	53
2024 Q3	$1.15M	Hold	282,036	–	–	0.1%	110
2024 Q2	$1.41M	Sell	282,036 -51,523	-15%	-$507K	0.14%	98
2024 Q1	$8.64M	Sell	333,559 -10,259	-3%	-$124K	0.85%	41
2023 Q4	$2.98M	Sell	343,818 -3,236	-0.9%	-$21.2K	0.3%	82
2023 Q3	$2.98M	Buy	347,054 +282,312	+436%	+$2.64M	0.38%	76
2023 Q2	$829K	Hold	64,742	–	–	0.1%	96
2023 Q1	$1.36M	Hold	64,742	–	–	0.13%	89
2022 Q4	$350K	Sell	64,742 -6,312	-9%	-$42.7K	0.03%	104
2022 Q3	$419K	Sell	71,054 -1,914	-3%	-$14K	0.04%	100
2022 Q2	$606K	Buy	72,968 +8,905	+14%	+$85.1K	0.05%	104
2022 Q1	$826K	Sell	64,063 -4,613	-7%	-$67.5K	0.06%	102
2021 Q4	$1.42M	Sell	68,676 -1,324	-2%	-$33.1K	0.09%	113
2021 Q3	$1.98M	Buy	+70,000	New	+$2.01M	0.12%	107